Aegon Asset Management Uk PLC Gilead Sciences, Inc. Transaction History

Aegon Asset Management Uk PLC

$6.67 Billion
Q1 2024

A detailed history of Aegon Asset Management Uk PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aegon Asset Management Uk PLC holds 289,271 shares of GILD stock, worth $19.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

289,271

Previous 789,666 63.37%

Holding current value

$19.3 Million

Previous $64 Million 66.89%

% of portfolio

0.32%

Previous 1.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$71.58 - $87.29 $35.8 Million - $43.7 Million	-500,395 Reduced 63.37%	289,271 $21.2 Million
Q4 2023 Jan 11, 2024	SELL	$73.27 - $83.09 $25.4 Million - $28.9 Million	-347,243 Reduced 30.54%	789,666 $64 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $682,797 - $778,826	-8,983 Reduced 0.78%	1,136,909 $87.5 Million
Q1 2023 Apr 14, 2023	SELL	$77.31 - $88.08 $7.4 Million - $8.43 Million	-95,661 Reduced 7.7%	1,145,892 $95 Million
Q4 2022 Oct 19, 2023	BUY	$62.32 - $89.47 $6.52 Million - $9.36 Million	104,644 Added 9.2%	1,241,553 $107 Million

Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $3.27 Million - $4.69 Million	-52,473 Reduced 4.06%	1,241,553 $107 Million
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $190,528 - $217,632	-3,200 Reduced 0.25%	1,294,026 $79.9 Million
Q2 2022 Jul 12, 2022	BUY	$57.72 - $65.01 $1.36 Million - $1.53 Million	23,585 Added 1.85%	1,297,226 $80.2 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $15.3 Million - $19.2 Million	264,227 Added 26.18%	1,273,641 $75.7 Million
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $312,981 - $355,239	-4,824 Reduced 0.48%	1,009,414 $73.3 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $603,591 - $651,208	-8,917 Reduced 0.87%	1,014,238 $70.8 Million
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $4.92 Million - $5.38 Million	-77,532 Reduced 7.04%	1,023,155 $70.4 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $12.2 Million - $14 Million	-204,030 Reduced 15.64%	1,100,687 $71.1 Million
Q4 2020 Jan 25, 2021	BUY	$56.65 - $64.55 $46.6 Million - $53.1 Million	822,466 Added 170.55%	1,304,717 $75.9 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $1.46 Million - $1.83 Million	23,431 Added 5.11%	482,251 $30.5 Million
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $33.2 Million - $38.5 Million	458,820 New	458,820 $35.3 Million
Q2 2018 Jul 10, 2018	SELL	$64.88 - $75.68 $28.1 Million - $32.7 Million	-432,423 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $1.26 Million - $1.54 Million	-17,330 Reduced 3.85%	432,423 $32.6 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $32.4 Million - $38.4 Million	449,753	449,753 $36.4 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.

Account

Aegon Asset Management Uk PLC Gilead Sciences, Inc. Transaction History